SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hemant surgical Industries zooms on inking pact with GBT Korea

02 Apr 2026 Evaluate

Hemant surgical Industries is currently trading at Rs. 266.25, up by 11.60 points or 4.56% from its previous closing of Rs. 254.65 on the BSE.

The scrip opened at Rs. 247.50 and has touched a high and low of Rs. 283.00 and Rs. 231.10 respectively. So far 27600 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 367.10 on 18-Sep-2025 and a 52 week low of Rs. 89.99 on 05-Jun-2025.

Last one week high and low of the scrip stood at Rs. 283.00 and Rs. 215.00 respectively. The current market cap of the company is Rs. 355.95 crore.

The promoters holding in the company stood at 58.90%, while Institutions and Non-Institutions held 10.96% and 30.14% respectively.

Hemant surgical Industries has entered into a C-ARM Development and Supply Agreement with GBT Korea Co., Republic of Korea to collaborate with their strong technological expertise to develop and localize x-ray generators, electronic control systems and c-arm imaging device utilizing fluoroscopy x-ray technology to provide real time high resolution imaging during surgical orthopaedic, trauma and cardio vascular procedures. 

Hemant surgical Industries is engaged in the business of manufacturing, importing, assembly and marketing of medical equipment and disposables.

Hemant Surgical Inds Share Price

291.85 3.85 (1.34%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 503.15
Poly Medicure 1656.20
Laxmi Denta 214.20
Nureca Ltd. 283.75
Hemant Surgical Inds 291.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×